Total Payments
$6,888
2024 Payments
$2,455
Companies
30
Transactions
385
Medicare Patients
541
Medicare Billing
$71,979
Payment Breakdown by Category
Food & Beverage$6,614 (96.0%)
Education$274.23 (4.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,614 | 382 | 96.0% |
| Education | $274.23 | 3 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,023 | 54 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $897.57 | 41 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $811.05 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $506.23 | 29 | $0 (2024) |
| Lundbeck LLC | $498.14 | 31 | $0 (2024) |
| ITI, Inc. | $436.88 | 36 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $426.50 | 15 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $367.91 | 26 | $0 (2024) |
| Alkermes, Inc. | $299.44 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $286.36 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,455 | 122 | Supernus Pharmaceuticals, Inc. ($360.23) |
| 2023 | $1,665 | 91 | Otsuka America Pharmaceutical, Inc. ($430.67) |
| 2022 | $1,192 | 75 | Otsuka America Pharmaceutical, Inc. ($199.54) |
| 2021 | $1,441 | 89 | Teva Pharmaceuticals USA, Inc. ($235.07) |
| 2020 | $134.44 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($35.03) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Central Nervous System | ||||||
| 12/13/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: ADHD | ||||||
| 12/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $124.46 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/28/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ADHD | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $71.49 | General |
| 10/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 125 | 264 | $53,272 | $20,684 |
| 2022 | 8 | 206 | 402 | $65,415 | $25,135 |
| 2021 | 8 | 181 | 328 | $55,250 | $24,141 |
| 2020 | 1 | 29 | 29 | $4,350 | $2,020 |
Total Patients
541
Total Services
1,023
Medicare Billing
$71,979
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 196 | $39,200 | $15,887 | 40.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 20 | 20 | $5,000 | $2,532 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 35 | $7,122 | $1,776 | 24.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 12 | 13 | $1,950 | $489.18 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 157 | $31,400 | $12,768 | 40.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 39 | 83 | $10,375 | $3,240 | 31.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 18 | 18 | $4,500 | $2,522 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,400 | $2,305 | 42.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 33 | 46 | $6,900 | $1,904 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 27 | $4,050 | $1,436 | 35.4% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 20 | 30 | $2,250 | $909.17 | 40.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 16 | 21 | $540.00 | $49.97 | 9.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 113 | $22,600 | $10,264 | 45.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 35 | 81 | $12,150 | $5,507 | 45.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 33 | 58 | $7,250 | $2,918 | 40.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 21 | 21 | $5,250 | $2,677 | 51.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $2,825 | $1,066 | 37.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $1,950 | $760.32 | 39.0% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 17 | 17 | $1,275 | $531.20 | 41.7% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Office | 2021 | 13 | 13 | $1,950 | $418.04 | 21.4% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Office | 2020 | 29 | 29 | $4,350 | $2,020 | 46.4% |
About Dr. Patrick Chau, M.D
Dr. Patrick Chau, M.D is a Child & Adolescent Psychiatry healthcare provider based in Sioux City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992766299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Chau, M.D has received a total of $6,888 in payments from pharmaceutical and medical device companies, with $2,455 received in 2024. These payments were reported across 385 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,614).
As a Medicare-enrolled provider, Chau has provided services to 541 Medicare beneficiaries, totaling 1,023 services with total Medicare billing of $71,979. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Location Sioux City, IA
- Active Since 03/28/2006
- Last Updated 09/12/2024
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1992766299
Products in Payments
- REXULTI (Drug) $1,178
- CAPLYTA (Drug) $717.36
- HETLIOZ (Drug) $625.90
- INGREZZA (Drug) $367.91
- Qelbree (Drug) $360.23
- ARISTADA (Drug) $299.44
- AUSTEDO (Drug) $291.63
- TRINTELLIX (Drug) $264.10
- Austedo XR (Drug) $258.58
- INVEGA SUSTENNA (Drug) $255.01
- ABILIFY MAINTENA (Drug) $216.77
- SPRAVATO (Drug) $186.27
- FANAPT (Drug) $185.15
- Azstarys (Drug) $151.10
- COBENFY (Drug) $142.80
- VRAYLAR (Drug) $140.17
- Auvelity (Drug) $100.08
- BRINTELLIX (Drug) $98.94
- SUNOSI (Drug) $81.15
- UZEDY (Drug) $73.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.